These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3882680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P, Hardison CD.
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of morning versus evening fluoxetine administration.
    Usher RW, Beasley CM, Bosomworth JC.
    J Clin Psychiatry; 1991 Mar; 52(3):134-6. PubMed ID: 2005078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.
    Beasley CM, Bosomworth JC, Wernicke JF.
    Psychopharmacol Bull; 1990 Mar; 26(1):18-24. PubMed ID: 2196623
    [Abstract] [Full Text] [Related]

  • 9. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD.
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD, Holman SL, Sayler ME, Potvin JH.
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [Abstract] [Full Text] [Related]

  • 13. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF, Sayler ME, Koke SC, Pearson DK, Tollefson GD.
    Depress Anxiety; 1997 Feb; 6(1):31-9. PubMed ID: 9394873
    [Abstract] [Full Text] [Related]

  • 14. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD, Birkett M, Koran L, Genduso L.
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fluoxetine: activating and sedating effects.
    Beasley CM, Potvin JH.
    Int Clin Psychopharmacol; 1993 Oct; 8(4):271-5. PubMed ID: 8277147
    [Abstract] [Full Text] [Related]

  • 17. What constitutes an adequate antidepressant trial for fluoxetine?
    Schweizer E, Rickels K, Amsterdam JD, Fox I, Puzzuoli G, Weise C.
    J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
    [Abstract] [Full Text] [Related]

  • 18. Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorder.
    von Bardeleben U, Holsboer F, Gerken A, Benkert O.
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():31-5. PubMed ID: 2644337
    [Abstract] [Full Text] [Related]

  • 19. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.